Dexcom has promoted its Executive Vice President and Chief Financial Officer, Jereme Sylvain, to the expanded role of EVP, Chief Operating Officer and Chief Financial Officer, effective September 14, 2026. In this dual capacity, Mr. Sylvain will now oversee the company's global operations and quality teams, aiming to enhance alignment and operational efficiency as Dexcom pursues its growth strategy.
Key Details
- Effective Date: The promotion and expanded role became effective on September 14, 2026.
- New Compensation: In connection with the promotion, Mr. Sylvain's new annual base salary is $767,000, with an annual target bonus opportunity of 75% of his base salary.
- Expanded Responsibilities: Mr. Sylvain will retain his duties as Chief Financial Officer while adding oversight of Dexcom's global operations and quality teams.